A detailed history of Pro Share Advisors LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 7,984 shares of RXST stock, worth $119,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,984
Previous 10,229 21.95%
Holding current value
$119,121
Previous $351,000 42.74%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

SELL
$24.37 - $35.84 $54,710 - $80,460
-2,245 Reduced 21.95%
7,984 $201,000
Q4 2024

Feb 13, 2025

BUY
$33.66 - $54.73 $116,026 - $188,654
3,447 Added 50.83%
10,229 $351,000
Q3 2024

Nov 13, 2024

BUY
$40.78 - $57.04 $121,279 - $169,636
2,974 Added 78.1%
6,782 $335,000
Q2 2024

Aug 13, 2024

SELL
$50.42 - $64.29 $65,546 - $83,577
-1,300 Reduced 25.45%
3,808 $229,000
Q1 2024

May 08, 2024

BUY
$35.51 - $57.92 $181,385 - $295,855
5,108 New
5,108 $263,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $412M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.